Cardiovascular systems, inc. (CSII)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities
Net loss

-2,889

-3,401

-5,780

1,469

672

492

-2,888

3,737

365

-413

-1,977

772

-1,749

1,043

-1,858

-4,884

-22,716

-15,163

-13,261

-8,669

-10,656

-5,273

-8,224

-9,628

-9,712

-8,658

-7,292

-6,841

-6,219

-5,767

-5,210

-4,605

-4,191

-4,135

-3,859

-2,483

-2,384

-1,990

-4,268

Adjustments to reconcile net loss to net cash from operating activities
Amortization of intangible assets

337

337

234

61

127

55

53

51

51

53

49

-665

52

24

807

16

71

58

86

25

64

41

41

-14

36

74

28

-74

144

-34

34

-

-

-

-

-

-

-

-

Depreciation of property and equipment

751

753

740

768

805

776

801

803

939

994

994

985

992

983

957

958

918

923

887

858

541

384

367

348

316

286

293

265

135

299

204

181

188

227

221

186

139

173

164

Write-off of patent costs

146

266

505

-

200

300

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for doubtful accounts

150

375

75

0

25

50

50

-

-

-

100

150

125

40

150

-

75

350

175

-

175

150

696

-

100

100

90

40

25

50

80

-

-

-

-

-

-

-

-

Stock-based compensation

3,273

3,290

3,906

2,666

2,674

2,770

3,156

2,422

2,140

2,670

3,070

2,018

2,403

2,483

3,450

2,585

3,173

3,112

4,107

3,679

3,956

3,510

3,573

3,246

2,827

2,555

2,300

2,126

1,876

1,685

1,755

1,246

1,200

1,263

1,456

1,247

1,316

1,916

1,989

Accretion (Amortization) of Discounts and Premiums, Investments

3

236

-94

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on debt, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

145

-8

-14

-3

-21

-21

-21

-26

-15

-6

-

-

-58

67

Debt conversion and valuation of conversion options, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-574

-142

162

-455

-276

388

-1,372

1,202

-180

-386

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

250

Changes in assets and liabilities
Accounts receivable

-4,819

1,584

-1,316

1,045

5,089

-364

-855

-716

4,155

495

-1,056

745

2,604

1,130

1,330

205

-2,629

-1,112

-3,791

-290

5,331

3,838

1,689

1,665

3,675

747

631

-417

2,192

-397

-97

685

530

668

-1,492

-256

2,669

120

1,185

Inventories

2,597

1,983

1,431

-1,246

-375

1,584

1,490

-397

-399

366

138

292

436

-718

-553

-786

-11

2,791

1,480

747

-738

-687

1,754

1,001

1,606

2,017

2,023

-553

-365

199

-99

-763

-139

908

1,237

953

544

-135

137

Prepaid expenses and other assets

-424

-123

-763

1,040

478

-297

-828

571

-87

-3,435

643

1,670

2,089

-622

-1,314

1,626

-237

-1,074

-1,043

1,349

121

430

-717

828

-458

205

-11

56

-400

-180

-401

693

-261

-172

119

72

-309

-412

326

Accounts payable

-3,414

3,350

2,059

-1,349

436

-992

2,471

648

64

-837

229

1,571

1,218

-1,285

257

430

-314

-1,068

-18

-245

1,622

-2,213

1,417

-1,587

2,563

70

1,329

1,016

1,250

-643

-156

378

-561

430

22

693

374

-924

1,685

Accrued expenses and other liabilities

-260

2,848

-7,490

2,774

2,012

2,423

-4,291

368

1,494

-3,199

-5,240

110

4,591

2,400

-6,376

-1,898

13,263

-326

-166

-1,279

4,945

339

382

2,748

2,885

953

143

1,199

1,687

-1,718

1,313

-64

1,135

-674

-390

-1,291

-390

-1,091

370

Deferred revenue

-381

-386

-523

-537

-377

-151

-819

-388

577

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by operating activities

356

3,940

-5,720

5,300

1,382

4,800

-1,274

7,992

2,507

1,675

-2,500

3,105

2,661

15,898

-2,076

-3,383

-2,645

-12,719

-4,836

-7,272

-3,968

-6,643

-4,474

-8,542

-5,808

-6,870

-5,618

-1,401

-2,077

-5,495

-1,792

-2,873

-2,275

-4,158

-2,034

-1,211

-3,696

-2,063

-1,391

Cash flows from investing activities
Purchases of property and equipment

1,058

537

543

379

1,292

398

596

342

345

700

569

140

360

199

282

573

453

945

1,847

3,732

5,335

8,277

2,981

11,532

468

430

287

787

492

229

164

-73

84

330

96

349

73

459

200

Payments To Acquire Intangible Assets Purchased

0

0

5,741

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Debt Securities, Available-for-sale

13,124

0

4,844

-

-

-

0

-

-

-

-

-

-

-

-

0

0

20

17

18

10

0

2,084

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of convertible note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

350

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales of marketable securities

4,805

85

0

53

0

46

51

50

48

49

47

46

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

14,400

2,000

7,400

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs incurred in connection with patents

144

248

325

225

190

396

79

233

258

167

455

348

121

205

170

301

57

295

160

321

91

430

113

237

80

261

124

208

184

231

160

153

173

91

121

134

190

212

120

Net cash provided by (used in) investing activities

4,129

1,300

-4,053

-48,443

-4,537

-748

-624

-2,888

-555

-675

-977

-442

-481

-404

-452

375

-510

-1,260

-2,374

-4,071

-5,071

-8,707

-5,178

-11,769

-548

-691

-411

-995

-676

-460

-324

-80

-257

-421

-217

-483

-263

-671

-320

Cash flows from financing activities
Payments of employee taxes related to vested restricted stock

361

379

5,506

83

331

319

1,058

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Exercise of stock options

-

-

0

0

0

125

71

0

0

207

306

261

727

4,191

84

0

0

987

19

178

1,180

111

683

44

7,121

6,538

2,559

582

1,941

3,404

0

389

429

385

3,225

-

-

-

-

Payments on borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,200

1,200

1,200

1,450

6,000

1,200

1,200

1,200

1,200

1,200

0

0

978

957

-

-

-

-

Proceeds from financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

6,385

1,500

-

-

-

-

Proceeds from (Payments for) Other Financing Activities

-19

-20

-19

-18

-6

-7

-5

-6

8

6

6

4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-380

1,288

-5,525

2,100

-337

1,350

-992

1,851

8

1,598

312

2,119

21,671

5,591

84

1,472

0

2,657

19

1,700

1,180

271

-517

924

5,671

90,998

1,359

361

43,462

2,965

-1,200

16,027

429

6,461

3,768

-

-

-

-

Net change in cash and cash equivalents

4,105

6,528

-15,298

-41,043

-3,492

5,402

-2,890

6,955

1,960

2,598

-3,165

4,782

23,851

21,085

-2,444

-1,536

-3,155

-11,322

-7,191

-9,643

-7,859

-15,079

-10,169

-19,387

-685

83,437

-4,670

-2,035

40,709

-2,990

-3,316

13,074

-2,103

1,882

1,517

2,541

-3,922

534

-1,711

Conversion of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,276

1,809

3,327

4,979

255

-12

30

-

-

-

-

-

-

-

-

-

-

-

-